Abiopharma

🔍 Caron Michelle Elizabeth (Executive)

Company: A10 Networks, Inc. (ATEN)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 13,706 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 33,390.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,989 shares of Common Stock (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 36,379.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,994 shares of Common Stock at $27.13 per share (Direct)
  Date: 2026-05-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 33,385.00 | transaction_form_type: 4 | Footnotes: F3
• Sold 13,706 shares of Performance-based Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2029-09-30 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 2,989 shares of Performance-based Restricted Stock Units (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2030-02-12 | equity_swap_involved: 0 | shares_owned_after: 2,989.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Performance-Based Restricted Stock Units were previously reported on October 2, 2025, each of which represents a contingent right to receive one share of common stock of ATEN, with vesting subject to the achievement of a specified level of the volume weighted average closing price of a share of ATEN common stock during any one hundred (100) day trading period between September 30, 2025 and September 30, 2029. The achievement date occurred on April 16, 2026, as certified by the compensation committee of ATEN, resulting in 13,706 units meeting the appropriate performance-based conditions. However, these shares remain subject to time-based vesting conditions and will therefore vest as to one-half (1/2) on May 5, 2026 and an additional one-fourth (1/4) on each of the first and second anniversaries of April 16, 2026, subject to continued employment. These shares are reflected on Table I.
• F2: Performance-Based Restricted Stock Units that were previously reported on February 13, 2026, each of which represents a contingent right to receive one share of common stock of ATEN, with vesting subject to the achievement of specified levels of the volume weighted average closing prices of a share of ATEN common stock during any one hundred (100) day trading period between February 12, 2026 and February 12, 2030. The first achievement date occurred on April 22, 2026, as certified by the compensation committee of ATEN, resulting in 2,989 units meeting the appropriate performance-based conditions. However, these shares remain subject to time-based vesting conditions and will therefore vest as to one-half (1/2) on May 5, 2026 and an additional one-fourth (1/4) on each of the first and second anniversaries of April 22, 2026, subject to continued employment. These shares are reflected on Table I.
• F3: Includes 2,458 shares and 536 shares automatically withheld, on a non-discretionary basis, for tax purposes related to a September 30, 2025 performance-based restricted stock unit grant and a February 12, 2026 performance-based restricted stock unit grant, respectively, each that vested on May 5, 2026.